Increased Mortality and Comorbidity Risks Linked to Generalized Pustular Psoriasis

Just now September 24, 2026 1 min read 📰 Medical Xpress

📋 Key Takeaway

A study published in Frontiers in Immunology reveals that generalized pustular psoriasis (GPP) has higher mortality and comorbidity risks compared to psoriasis vulgaris (PV) and nonpsoriatic controls. This finding underscores the health challenges faced by individuals with GPP, which may have implications for healthcare policies in Iran. Understanding these risks is crucial for improving patient care in the region.

Generalized pustular psoriasis (GPP) is associated with higher mortality and comorbidity risks than psoriasis vulgaris (PV), according to a study published online Sept. 2 in Frontiers in Immunology. The risks also were higher than those among nonpsoriatic controls.